A carregar...
Prospect for Application of PARP Inhibitor in Patients with HER2 Negative Breast Cancer
Human epidermal growth factor receptor (HER2) negative metastatic breast cancer (BC) accounts for 73% of BC. The molecular analysis of this disease is essential for potential options for targeted therapy. Several promising clinical strategies are being evaluated which includes endocrine therapy, mod...
Na minha lista:
| Publicado no: | Int J Biol Sci |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Ivyspring International Publisher
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6535782/ https://ncbi.nlm.nih.gov/pubmed/31182917 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijbs.30721 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|